Our Work in Mexico

For Everyone

At a glance

CDC works with the Mexico Ministry of Health (SALUD) to prevent, detect and respond to public health threats that can affect people in the United States and Mexico. This partnership strengthens disease surveillance, laboratory capacity, public health preparedness, and antimicrobial resistance efforts, and helps protect U.S. health security.

Zocalo Square and Metropolitan Cathedral of Mexico City.

About the CDC Mexico Country Office

CDC established the CDC Mexico Country Office (CDC Mexico) in 2011. CDC Mexico collaborates with Mexican health officials to prevent, detect, and respond to infectious disease threats that can affect people in both countries, including binational communities and mobile populations.

CDC Mexico provides technical support for:

  • Investigating and controlling infectious disease outbreaks of binational and international importance
  • Strengthening binational disease surveillance and laboratory capacity
  • Improving public health preparedness and response
  • Supporting communication and coordination between U.S. and foreign government officials on policies critical to binational health

CDC's impact in Mexico

Binational Technical Working Group (BTWG)

Established in 2012, the BTWG brings together CDC, SALUD, and public health officials from the U.S. and Mexico border states to address shared public health concerns in the U.S.-Mexico border region.

Members exchange information on infectious diseases, epidemiologic trends, research, and public health tools. This coordination helps both countries identify priorities, develop binational public health initiatives, and strengthen preparedness and response.

BTWG meeting topics include

  • Measles
  • New World screwworm
  • Rocky Mountain spotted fever
  • Combating antimicrobial-resistant bacteria
  • Medical tourism

Disease surveillance

CDC Mexico collaborates with the Binational Border Infectious Disease Surveillance (BIDS) program, which works with U.S. southern border states, to improve detection, reporting, and prevention of infectious diseases of binational importance.

Since 2023, CDC Mexico has supported SALUD in developing a national antimicrobial resistance (AMR) surveillance system and supporting Laboratory Response Network capacity and coordination.

Did you know?

As of 2025, more than 208,000 health professionals in Mexico had completed the AMR training and all 32 state laboratories had received training on new AMR laboratory protocols developed by Mexico's National Institute of Epidemiological Diagnosis and Reference (InDRE).

Tuberculosis (TB)

TB remains a leading cause of infectious disease deaths worldwide. CDC Mexico provides technical support for TB prevention and control in Mexico and works with the CureTB program to help people continue TB treatment when they move between the United States and Mexico.

CDC Mexico supports Mexico's National Action Program for the Prevention and Control of Tuberculosis to improve TB prevention and diagnosis. This includes studying the use of TB blood tests among people at higher risk for developing TB disease.

In previous years, CDC supported SALUD in developing Mexico's national TB surveillance platform, which is now used to collect TB case data nationwide.

Laboratory

Strong laboratory systems help public health officials detect infectious disease threats early and respond before they spread more widely.

CDC Mexico works with SALUD to strengthen surveillance and laboratory capacity, focusing on infectious disease monitoring, early detection, and rapid response capabilities, in the U.S.-Mexico border regions and throughout Mexico. CDC Mexico's long-standing collaboration with InDRE has strengthened laboratory capacity to detect and respond to avian influenza, pertussis (whooping cough), tuberculosis, and other infectious disease threats.

Laboratory scientists looking at lab specimen samples
American Society for Microbiology representatives visit a laboratory supporting surveillance for Bordetella pertussis (the bacterium that causes pertussis or whooping cough) in collaboration with InDRE.

Influenza

CDC and SALUD have collaborated on influenza surveillance for decades. Year-round surveillance helps detect seasonal influenza viruses and identify new influenza A viruses could cause a pandemic. The collaboration also strengthens reporting and information sharing.

Vector-borne and parasitic diseases

From 2024 to 2025, CDC provided over $200,000 to support Mexico's Rocky Mountain spotted fever (RMSF) program. This work strengthened clinical, surveillance, and response capacity in northern Mexico. In 2025, more than 2000 physicians in priority municipalities of Baja California, Chihuahua, Sonora, and Nuevo León received RMSF training. Mexico also developed and disseminated a clinical tool, "Clinical Algorithm for Diagnosis and Initial Management of RMSF," to help healthcare providers diagnose and initially manage RMSF.

In 2026, CDC provided $150,000 to strengthen surveillance and laboratory capacity for New World Screwworm myiasis in Mexico. This work supports earlier case detection, improves understanding of human transmission, and informs prevention and control efforts as part of national and regional One Health preparedness.

Policy, communications, and diplomacy

CDC maintains regular communication with SALUD and other public health partners to share information and coordinate responses to emerging health threats.

These partnerships help the United States and Mexico respond more quickly to shared public health challenges and strengthen long-term collaboration between the two countries.

Content Source
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
About this page
Published: May 15, 2024
Updated: November 13, 2026

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: November 13, 2026

The information on this page was last reviewed by subject matter experts to ensure accuracy.